News

IMBA Forscher erhält renommierte Förderung des Europäischen Forschungsrates

Exploring the molecular basis of heredity: ERC grant for Joao Matos

ERC Consolidator Grant awarded to CeMM Principal Investigator Christoph Bock

HOOKIPA Interim Phase 1 Monotherapy Data of HB-201 for the Treatment of Advanced HPV16+ Cancers Shows Promising Anti-Tumor Activity and Favorable Tolerability

Nasenspray statt Nasen-Mund-Maske

20.000 Euro für schwerstkranke Kinder

Vollständigen Schutz von Probiotika vor der Zerstörung durch Magensäure und Gallenflüssigkeit gewährleistet die Bac-in-a-Box® Verkapselungstechnologie

APEIRON Biologics: Patient recruitment completed in Phase II COVID-19 Clinical Trial of APN01

PHAGOMED SELECTED AS LEADING YOUNG EUROPEAN BIOTECH COMPANY

Valneva Announces Acceleration of Pediatric Development for Lyme Disease Vaccine Candidate

Vivaldi Biosciences Files Patent Application for Delta-19 Combination Covid-19 + Universal Influenza Vaccine

Forschungsförderung: Rund 140 Mio. Euro fehlen

AI-software developer ImageBiopsy Lab partners with leading medical device company to support radiologists in faster and more accurate diagnosis of MSK images

TU Wien präsentiert den schnellsten Corona-Test der Welt

LEADING SUPERCOMPUTER CLUSTER STARTS OPERATIONS AT IMBA AND THE VIENNA BIOCENTER

OpGen Group Company Ares Genetics Advances ares-genetics.cloud Platform, Presents Update at Scientific Conferences, Expects Granting of Key Patent

ams Wins Federal Funding in Austria to Bolster Pandemic Control Through a Highly-accurate, Cloud-connected Lateral Flow Test Device for SARS-CoV-2 (COVID-19) Providing Test Results in Around 15 Minutes

Qualität ist oberste Priorität in der Impfstoffproduktion

Thomas Henzinger erneut zum Präsidenten des IST Austria ernannt

HEALTH APPS ON PRESCRIPTION?